ARHGAP31-AS1

Across TCGA pan-cancer cohorts, ARHGAP31-AS1 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated ARHGAP31-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ARHGAP31-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ARHGAP31-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRC show a favorable association.

ACC, UCS, and KIRC are the cancer types where ARHGAP31-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Median	All	0.421	0.740	<.001	80	view →
UCS	DFS	Tertile	II,III,IV	0.641	0.132	.001	70	view →
KIRC	OS	Quartile	All	0.735	0.514	<.001	68	view →
MESO	OS	Median	All	0.286	0.483	.002	63	view →
LIHC	OS	Median	II,III,IV	0.466	0.744	<.001	39	view →
LGG	OS	Tertile	All	0.945	0.837	<.001	29	view →
HNSC	OS	Quartile	III,IV	0.322	0.717	.002	28	view →
UVM	OS	Quartile	All	0.813	0.403	.004	26	view →
KIRP	DFS	Quartile	All	0.918	0.551	.008	18	view →
THCA	OS	Median	II,III,IV	0.933	1.000	.015	16	view →
CHOL	DFS	Median	III,IV	0.127	0.647	.006	12	view →
LUSC	DFS	Quartile	III,IV	0.405	0.951	.008	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 26 lineages.

ARHGAP31-AS1–ACC (DFS)

Open the ACC breakdown →